Physician

Renu Gupta, M.D.

According to 2025 Medicare claims, Renu Gupta, M.D. (NPI: 1609062439) practices nephrology in the Medford, OR market, with the plurality of this provider's patient population coming from Jackson, OR. This provider's primary affiliated billing organization is RENAL CARE CONSULTANTS PC (NPI: 1740344597; TIN: 931274002) and primary practice location at 97504-9685. Gupta is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Gupta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 392 traditional Medicare patients, billed 7,224 HCPCS/CPT codes, and received $336,922 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,461 prescription claims across 392 beneficiaries totaling $223,222 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 275 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $174,728 and ending at $223,222. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $2,945 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	634	2,786	$208,644
2016	680	2,780	$204,544
2017	551	2,114	$136,612
2018	624	2,697	$187,458
2019	642	2,176	$182,500
2020	487	2,355	$191,080
2021	485	2,181	$196,265
2022	395	1,456	$160,094
2023	394	3,909	$233,823
2024	392	7,224	$336,922

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	345	2,379	$174,728
2016	347	2,662	$236,829
2017	300	2,109	$184,547
2018	309	2,054	$124,314
2019	341	2,144	$79,652
2020	371	2,763	$148,595
2021	355	2,635	$183,562
2022	362	2,410	$222,771
2023	377	2,408	$303,868
2024	392	2,461	$223,222

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	119	$6,039
2016	N/R	56	$1,375
2017	N/R	91	$1,630
2018	N/R	95	$1,907
2019	N/R	185	$5,015
2020	N/R	231	$8,065
2021	N/R	96	$3,109
2022	N/R	191	$5,882
2023	N/R	273	$7,157
2024	N/R	275	$6,411

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	230	354	$62
99457	Management using the results of remote vital sign monitoring per calendar month, first 20 minutes	118	1,134	$40
99454	Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days	109	1,050	$39
99458	Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes	111	2,373	$33
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	224	388	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	48	2,902	$46,717
Jardiance	Empagliflozin	29	1,470	$26,003
Cinacalcet Hcl	Cinacalcet Hcl	15	810	$10,236
Calcitriol	Calcitriol	468	32,311	$8,624
Sevelamer Carbonate	Sevelamer Carbonate	31	1,562	$3,925

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	60	$1,574
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	28	$1,196
J7500	Azathioprine, oral, 50 mg	N	N/R	14	$1,150
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	79	$1,053
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	57	$1,016

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Renu Gupta, M.D.?

Tedicare shows public-source Medicare data for Renu Gupta, M.D. (NPI 1609062439), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Renu Gupta, M.D. have ACO affiliation data?

Renu Gupta, M.D. is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Renu Gupta, M.D.?

Renu Gupta, M.D. is linked to RENAL CARE CONSULTANTS PC (billing NPI 1740344597) in the available physician profile data.

Does Renu Gupta, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.